Cormorant Asset Management, LP Arcellx, Inc. Transaction History

Cormorant Asset Management, LP

$943 Million
Q1 2025

A detailed history of Cormorant Asset Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,050,000 shares of ACLX stock, worth $68.4 Million. This represents 7.31% of its overall portfolio holdings.

Number of Shares

1,050,000

Previous 1,300,000 19.23%

Holding current value

$68.4 Million

Previous $99 Million 30.43%

% of portfolio

7.31%

Previous 7.82%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$60.26 - $79.13 $15.1 Million - $19.8 Million	-250,000 Reduced 19.23%	1,050,000 $68.9 Million
Q4 2024 Feb 14, 2025	BUY	$75.39 - $106.53 $3.77 Million - $5.33 Million	50,000 Added 4.0%	1,300,000 $99 Million
Q3 2024 Nov 14, 2024	SELL	$50.91 - $86.61 $14 Million - $23.8 Million	-275,000 Reduced 18.03%	1,250,000 $104 Million
Q2 2024 Aug 14, 2024	SELL	$49.74 - $66.98 $12.7 Million - $17.1 Million	-255,000 Reduced 14.33%	1,525,000 $84.2 Million
Q1 2024 May 15, 2024	BUY	$51.85 - $73.49 $4.15 Million - $5.88 Million	80,000 Added 4.71%	1,780,000 $124 Million
Q4 2023 Feb 14, 2024	SELL	$31.75 - $57.99 $14.3 Million - $26.1 Million	-450,000 Reduced 20.93%	1,700,000 $94.4 Million
Q3 2023 Nov 14, 2023	BUY	$31.51 - $37.4 $4.73 Million - $5.61 Million	150,000 Added 7.5%	2,150,000 $77.1 Million
Q2 2023 Aug 14, 2023	BUY	$27.49 - $46.9 $11 Million - $18.8 Million	400,000 Added 25.0%	2,000,000 $63.2 Million
Q1 2023 May 15, 2023	SELL	$26.92 - $33.94 $12.8 Million - $16.1 Million	-475,000 Reduced 22.89%	1,600,000 $49.3 Million
Q4 2022 Feb 14, 2023	SELL	$17.18 - $33.0 $16.7 Million - $32.1 Million	-974,173 Reduced 31.95%	2,075,000 $64.3 Million
Q3 2022 Nov 14, 2022	BUY	$16.67 - $22.04 $25.4 Million - $33.6 Million	1,524,173 Added 99.95%	3,049,173 $57.2 Million
Q2 2022 Aug 15, 2022	BUY	$7.21 - $24.43 $11 Million - $37.3 Million	1,525,000 New	1,525,000 $27.6 Million

Others Institutions Holding ACLX

# of Institutions

214

Shares Held

48.8M

Call Options Held

764K

Put Options Held

296K

View Full List

About Arcellx, Inc.

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.85B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

More about ACLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Arcellx, Inc. Transaction History